๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ahmedabad
Clinical trial register · India

Clinical Trials in Ahmedabad

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1123 matching records held by the registry are in this view. Synced 21 Sep 2026, 03:16 UTC
1123
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 332 Mumbai 259 Hyderabad 237 Bangalore 193 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca25 Eli Lilly and Company16 Novartis Pharmaceuticals12 Bristol-Myers Squibb12 Hoffmann-La Roche7
Site location
New Delhi332 Mumbai259 Hyderabad237 Bangalore193 Pune189
All 274 locations
Target enrolment
to
157 of 1123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Active, closed
Assessing the Effects of Cool Roofs on Mental Health in Ahmedabad, India
NCT07251218Eco-anxiety, PTSD - Post Traumatic Stress Disorder, Resilience, Anxiety
Aditi Bunker
Not applicable
800
Ahmedabad
2024-12-01
Active, closed
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56
NCT06683742Wet Age Related Macular Degeneration, wAMD
EyePoint Pharmaceuticals, Inc.
Phase 3
400
Ahmedabad, Kolkata, Miraj, Mumbai, Varanasi
2024-11-27
Recruiting
An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older
NCT06666491Malaria, Vivax
GlaxoSmithKline
Phase 3
300
Ahmedabad, Kolkata, Mumbai, Surat
2024-11-13
Active, closed
A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent ฮฒ-thalassemia, Using MRI Scans to Measure Iron Levels in the Body
NCT06421636Non-Transfusion Dependent Beta-Thalassemia (NTDT)
Regeneron Pharmaceuticals
Phase 2
19
Ahmedabad, Surat, Kochi, Mumbai, New Delhi, Jaipur
2024-09-30
Recruiting
Assessing the Effects of Cool Roofs on Indoor Environments and Health
NCT06579950Resting Heart Rate, Blood Glucose Control, Depression, Heat-related Symptoms
Aditi Bunker
Not applicable
3,200
Ahmedabad
2024-09-04
Recruiting
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
NCT06058585Chronic Kidney Diseases
The George Institute
Phase 3
1,000
Visakhapatnam, Patna, Raipur, Dehradun, Ahmedabad, Mangaluru, Meppฤdi, Indore
2024-09-04
Active, closed
Assessing the Effect of Cool Roofs on Health Using Smartwatches
NCT06579963Heart Rate, All-day Steps, Distance Walked, Active Minutes
Aditi Bunker
Not applicable
800
Ahmedabad
2024-09-04
Active, closed
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
NCT06455202Chronic Spontaneous Urticaria
Celldex Therapeutics
Phase 3
976
Surat, Vadodara, Nagpur, Nashik, Pune, Jaipur, Kanpur, Ahmedabad
2024-07-19
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
NCT06226883Inflammatory Bowel Diseases, Crohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Ahmedabad, Bhubaneswar, Chennai, Coimbatore, Jaipur, Kochi, Ludhiana, New Delhi
2024-07-18
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
NCT06024746Heart Failure
Colorado Prevention Center
Phase 3
1,500
Ahmedabad, Bangalore, Nagpur, New Delhi
2024-07-09
Active, closed
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
NCT06118281Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Novo Nordisk A/S
Phase 3
10,000
Guntur, Visakhapatnam, Raipur, Ahmedabad, Surat, Vadodara, Bengaluru, Mangaluru
2024-06-25
Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
NCT06455449Polymyositis, Dermatomyositis
AstraZeneca
Phase 3
240
Ahmedabad, Dehradun, Delhi, Gurugram, Hyderabad, Kolkata, Lucknow, Mumbai
2024-06-20
Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
NCT06133972Systemic Lupus Erythematosus
Novartis Pharmaceuticals
Phase 3
550
Ahmedabad, Kozhikode, Kolhฤpur, Nagpur, Nashik, Pune, New Delhi
2024-05-21
Recruiting
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
NCT06372964Bipolar Depression
Intra-Cellular Therapies, Inc.
Phase 3
384
Ahmedabad, Aurangabad, Nashik, Varanasi
2024-05-14
Active, closed
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
NCT06407934Dermatitis Atopic
Sanofi
Phase 3
1,541
Ahmedabad, Belagavi, Chandigarh, Faridabad, Kolkata, Nagpur, Pune
2024-05-08
Recruiting
'Glycogen Storage Diseases (GSDs) in Indian Children- Establishing an Indian GSD (I-GSD) Registry'
NCT06396546Glycogen Storage Diseases
Institute of Liver and Biliary Sciences, India
Observational
250
Guindy, Ahmedabad, Surat, Srinagar, Bengaluru, Mangalore, Kochi, Thiruvananthapuram
2024-05-02
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
NCT06307652Heart Failure and Impaired Kidney Function
AstraZeneca
Phase 3
3,850
Ahmedabad, Ajmer, Amritsar, Bangalore, Belagavi, Coimbatore, Dehradun, Delhi
2024-04-12
Active, closed
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
NCT06346392Gastric Cancer, Gastroesophageal Junction Cancer
AstraZeneca
Phase 3
594
Ahmedabad, Hyderabad, Mumbai, New Delhi
2024-03-04
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966COPD (Chronic Obstructive Pulmonary Disease)
AstraZeneca
Phase 3
5,000
Ahmedabad, Aligarh, Belagavi, Calicut, Chandigarh, Dehradun, Delhi, Dwฤrka
2024-02-21
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
NCT06008197Heart Failure, Acute Heart Failure
Colorado Prevention Center
Phase 3
5,200
Guntur, Vijayawada, Patna, Ahmedabad, Kochi, Nagpur, Nashik, New Delhi
2024-01-17
Recruiting
A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)
NCT06412250Cardiovascular Diseases
Translumina Therapeutics Pvt Ltd.
Observational
2,000
Ahmedabad, Bangalore, Bathinda, Chandigarh, Delhi, Gurugram, Hyderabad, Jabalpur
2024-01-10
Active, closed
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naรฏve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)
NCT06140836Carcinoma, Non-Small-Cell Lung
Bristol-Myers Squibb
Phase 3
190
Ahmedabad, Gurugram, Bengaluru, Pune, New Delhi
2023-12-21
Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
NCT06119581Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
1,264
Ahmedabad, Belagavi, Bengaluru, Bhubaneswar, Coimbatore, Hyderabad, Karad, Kolhฤpur
2023-12-21
Active, closed
A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia
NCT07052006Myelodysplastic Syndrome, Anemia in Myelodysplastic Syndromes
Halia Therapeutics, Inc.
Phase 2
37
Ahmedabad, Kannur, Visakhapatnam, Kolhฤpur, Dehradun, Madurai, Hyderabad, Kolkata
2023-12-09
Active, closed
Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.
NCT06042478Chronic Spontaneous Urticaria
Novartis Pharmaceuticals
Phase 3
470
Ahmedabad, Bangalore, Belagavi, Mysore, Nagpur, Nashik, New Delhi, Bikaner
2023-11-15
Rows per page Showing 51–75 of 157
Previous 1 2 3 4 5 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/ahmedabad

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.